SU 4312

Known as: SU-4312, SU4312 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2016
01220072016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
We have previously demonstrated the unexpected neuroprotection of the anti-cancer agent SU4312 in cellular models associated with… (More)
Is this relevant?
2016
2016
In vertebrates, the retinol (vitamin A) signaling pathway (RSP) controls the biosynthesis and catabolism of all-trans retinoic… (More)
Is this relevant?
2013
2013
BACKGROUND AND PURPOSE SU4312, a potent and selective inhibitor of VEGF receptor-2 (VEGFR-2), has been designed to treat cancer… (More)
Is this relevant?
2012
2012
Arsenic widely contaminates the environment, especially in drinking water. Although it is a known carcinogen in humans, its… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
It has recently been reported that relatively short-term inhibition of vascular endothelial growth factor (VEGF) signaling can… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Pathologic angiogenesis has emerged as an important therapeutic target in several major diseases. Zebrafish offer the potential… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
10.1038/nrc2235 Inhibition of tumour angiogenesis using therapies directed against vascular endothelial growth factor (VEGF) has… (More)
Is this relevant?